tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
Tiziana Life Sciences Plc (TLSA)
NASDAQ:TLSA
US Market
TLSA
Tiziana Life Sciences
Overview
Technical Analysis
Options
Chart
Earnings
Dividends
Ownership
Financials
Similar Stocks
RESEARCH TOOLS
Top Analyst Stocks
Top Smart Score Stocks
Stock Screener
reports
Holding TLSA?
Track your performance easily
Link Broker

Tiziana Life Sciences (TLSA) Stock News & Sentiment

566 Followers
Tiziana Life Sciences Reports Breakthrough in Spinal Cord Injury Treatment
Premium
Company Announcements
Tiziana Life Sciences Reports Breakthrough in Spinal Cord Injury Treatment
7d ago
6K
TLSA
Tiziana Life Sciences Unveils New Biomarkers in Treatment of Progressive Multiple Sclerosis
Premium
Company Announcements
Tiziana Life Sciences Unveils New Biomarkers in Treatment of Progressive Multiple Sclerosis
9d ago
6K
TLSA
Tiziana’s Nasal Therapy Reduces GLP-1 Side Effects
Premium
Company Announcements
Tiziana’s Nasal Therapy Reduces GLP-1 Side Effects
21d ago
6K
TLSA
Tiziana Life Sciences’ Foralumab Shows Promise in Neurodegenerative Disease Treatment
Premium
Company Announcements
Tiziana Life Sciences’ Foralumab Shows Promise in Neurodegenerative Disease Treatment
23d ago
6K
TLSA
Tiziana Life Sciences Advances Alzheimer’s Treatment with Intranasal Foralumab
Premium
Company Announcements
Tiziana Life Sciences Advances Alzheimer’s Treatment with Intranasal Foralumab
1M ago
6K
TLSA
Tiziana Life Sciences Expands MS Clinical Trial Network
Premium
Company Announcements
Tiziana Life Sciences Expands MS Clinical Trial Network
2M ago
6K
TLSA
Tiziana Life Sciences Secures ALS Trial Funding
Premium
Company Announcements
Tiziana Life Sciences Secures ALS Trial Funding
2M ago
6K
TLSA
More TLSA News >

TLSA News on the Web

Tiziana Life Sciences reports promising preclinical results for nasal anti-CD3 in spinal cord injury
Proactive Investors
Neutral
Tiziana Life Sciences not to engage in capital raising activities for the immediate future
Yahoo Finance
Neutral
Tiziana Life Sciences identifies new immune biomarkers in MS patients treated with foralumab
Proactive Investors
Neutral
Tiziana Life Sciences’ foralumab reduces side effects of discontinuing GLP-1 agonists
Proactive Investors
Neutral
Tiziana Life Sciences welcomes publication of article highlighting foralumab’s potential in neurolog
Proactive Investors
Neutral
Tiziana Life Sciences doses first Alzheimer’s patient with intranasal foralumab
Proactive Investors
Neutral
Tiziana Life Sciences doses first Alzheimer’s patient with intranasal foralumab
Proactive Investors
Neutral
Tiziana Life Sciences expands Phase 2 trial for non-active SPMS
Yahoo Finance
Neutral

News Score - Last 7 Days

Neutral
TLSA
Sector Average
Media Buzz
This Week0 articles
Weekly Average0 articles
News Sentiment
This Week50%
Sector Average64%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is TLSA’s Media Buzz Sentiment?
Currently, no data Available
What is TLSA’s weekly average amount of articles?
Currently, no data Available
What is TLSA’s News Sentiment?
50% of articles about TLSA were positive this week, compared to its sector average of 64%.
    Healthcare Stocks that are Trending in the News
    LNTHLantheus
    INBSIntelligent Bio Solutions
    AKROAkero Therapeutics
    DVADaVita
    FNAParagon 28
    Showing the stocks with the most bullish news sentiment over the past week

    Become an Expert with TipRanks Premium

    What am I Missing?
    Make informed decisions based on Top Analysts' activity
    Know what industry insiders are buying
    Get actionable alerts from top Wall Street Analysts
    Find out before anyone else which stock is going to shoot up
    Get powerful stock screeners & detailed portfolio analysis
    Subscribe NowSee Plans & Pricing